Antiphospholipid Syndrome: Symptoms, Causes, and Treatment Options

Antiphospholipid syndrome is an autoimmune condition in which the immune system makes antibodies that increase the risk of abnormal blood clots and certain pregnancy complications. With proper diagnosis, long-term follow-up, and treatment tailored to a person’s clotting history and overall health, many people can manage the condition well.

Overview

Antiphospholipid syndrome is an autoimmune disorder in which the body produces abnormal proteins called antiphospholipid antibodies. These antibodies can make the blood more likely to clot than usual, which may lead to problems such as deep vein thrombosis, stroke, or complications during pregnancy. The condition is often shortened to APS.

APS can occur on its own or alongside another autoimmune disease, especially lupus. Some people have antiphospholipid antibodies in their blood without ever developing symptoms, while others have repeated clotting events or pregnancy loss. This is why diagnosis depends on both a person’s medical history and carefully timed laboratory testing, not on a single blood test alone.

The effects of APS vary widely. One person may have swelling and pain from a leg clot, while another may be diagnosed after repeated miscarriages or an unexpected stroke at a younger age. A smaller number of people develop a rare, severe form called catastrophic APS, which causes widespread clotting and requires urgent specialist care.

How antiphospholipid syndrome affects the body

In APS, the immune system targets proteins that bind to phospholipids, which are normal components of cell membranes. The resulting antibodies can interfere with the body’s normal balance between clotting and bleeding. Instead of helping the blood flow smoothly, they may activate cells involved in clot formation and increase inflammation inside blood vessels.

These changes can affect veins, arteries, and the placenta during pregnancy. Venous clots often occur in the legs or lungs, while arterial clots may affect the brain, heart, or other organs. In pregnancy, APS can reduce healthy blood flow to the developing placenta, increasing the risk of miscarriage, stillbirth, preeclampsia, or growth problems in the baby.

Because clotting can happen in different parts of the body, symptoms may seem unrelated at first. Some people have skin changes, migraines, low platelet counts, or heart valve abnormalities in addition to classic clotting events. A broad, whole-person evaluation is often needed to understand whether APS is the cause.

Symptoms and possible complications

The symptoms of antiphospholipid syndrome depend on where a clot forms and whether pregnancy is affected. Some people have no symptoms until a major event occurs. Others may notice warning signs linked to poor circulation or previous unexplained pregnancy problems.

Possible symptoms and complications include:

• Swelling, pain, warmth, or redness in one leg from a deep vein clot
• Sudden shortness of breath or chest pain if a clot travels to the lungs
• Stroke-like symptoms such as weakness, facial drooping, trouble speaking, or vision changes
• Repeated miscarriages, especially after the first 10 weeks, or unexplained fetal loss
• Preeclampsia, premature birth, or poor fetal growth
• Livedo reticularis, a lace-like purplish skin pattern
• Low platelet count, headaches, or heart valve findings in some cases

These features are not unique to APS, which is one reason the condition may be overlooked. A clotting event in a younger person, recurrent pregnancy loss, or clotting without an obvious trigger may prompt doctors to investigate further. If neurological symptoms are present, evaluation may also overlap with assessment for conditions such as stroke.

In rare cases, catastrophic APS causes multiple clots in several organs over a short period of time. This is a medical emergency that can affect the kidneys, lungs, brain, or heart and requires rapid hospital treatment.

Causes and risk factors

The exact cause of antiphospholipid syndrome is not fully understood. It develops when the immune system makes antibodies such as lupus anticoagulant, anticardiolipin antibodies, or anti-beta-2 glycoprotein I antibodies. These antibodies do not always cause illness, but in some people they increase the tendency for clotting or pregnancy complications.

APS may be primary, meaning it occurs without another known autoimmune disease, or secondary, meaning it appears alongside a condition such as lupus. People being evaluated for overlapping autoimmune conditions may also need assessment for related disorders such as lupus. Genetic factors may influence susceptibility, but APS is not considered a simple inherited disease in the usual sense.

Several factors can raise the likelihood that someone with antiphospholipid antibodies will actually develop a clot. These include smoking, prolonged immobility, major surgery, estrogen-containing medications, pregnancy, obesity, high blood pressure, and other cardiovascular risk factors. Infections and some medications can sometimes cause temporary positive antibody tests, so doctors interpret results carefully and repeat them after a suitable interval.

How APS is diagnosed

Diagnosing APS requires more than one piece of evidence. Doctors usually consider the diagnosis when a person has a history of unexplained blood clots, recurrent miscarriage, stillbirth, severe preeclampsia, or certain other pregnancy complications. They then combine this history with blood tests that look for specific antiphospholipid antibodies.

The main laboratory tests are lupus anticoagulant, anticardiolipin antibodies, and anti-beta-2 glycoprotein I antibodies. To support a diagnosis of APS, these tests generally need to remain positive on repeat testing at least 12 weeks apart. This repeated testing is important because temporary positivity can happen during illness or after certain infections.

Doctors may also order additional blood work to check platelet count, kidney function, signs of inflammation, and whether another autoimmune disease is present. Imaging tests such as ultrasound, CT, or MRI may be needed to confirm a clot or evaluate symptoms in the lungs, brain, or abdomen. In some situations, people may need MRI imaging or a comprehensive medical check-up to assess organ effects and underlying risk factors.

Diagnosis in pregnancy requires special care because several conditions can mimic one another. Obstetric history, blood pressure patterns, fetal growth, and placental health all matter. A coordinated approach between hematology, rheumatology, and obstetrics is often helpful.

Treatment options and long-term management

Treatment for antiphospholipid syndrome aims to prevent new clots, reduce complications, and support a healthy pregnancy when relevant. The exact plan depends on whether the person has had a previous clot, which antibodies are present, whether pregnancy is involved, and whether another autoimmune disease is also being treated.

For people who have had a blood clot, long-term anticoagulation is commonly recommended. These medicines lower the chance of future clots, but they also require regular review because bleeding risk, procedures, and other medications may affect safety. Not everyone with positive antibodies needs the same treatment; some people without prior clots may only need monitoring and risk-factor control, while others with high-risk antibody patterns may need preventive treatment in specific situations.

Pregnancy-related APS is managed differently from non-pregnancy APS. Doctors may use medications considered safer during pregnancy and monitor both parent and baby closely throughout gestation. People planning pregnancy should ideally speak with their care team beforehand so treatment can be adjusted early. If symptoms suggest a new clot, urgent evaluation is important because treatment should not be delayed.

When APS occurs with another autoimmune disease, care may involve several specialists. Depending on symptoms, clinicians may also address vascular health, heart rhythm, or neurological recovery, and selected patients may require supportive services such as cardiology evaluation. Near the end of the care pathway, patients seeking cross-border care may also choose centers such as Acibadem International, where multidisciplinary specialists in JCI-accredited hospitals diagnose and treat complex autoimmune and clotting conditions for international patients.

Living with APS: prevention and self-care

Daily management plays an important role in reducing clot risk. People with APS are often advised to take medicines exactly as prescribed, keep follow-up appointments, and tell every healthcare professional involved in their care that they have a clotting disorder. This is especially important before surgery, dental procedures, pregnancy, or long-distance travel.

Helpful self-care steps may include:

• Avoiding smoking and secondhand smoke
• Staying active and avoiding long periods of immobility
• Maintaining a healthy weight and managing blood pressure, cholesterol, and diabetes if present
• Discussing birth control and hormone therapy options with a doctor
• Following travel advice, such as moving regularly and staying hydrated on long journeys
• Reporting unusual bruising, bleeding, or new symptoms while on anticoagulants

People taking blood thinners should also ask about interactions with over-the-counter medicines, supplements, and diet changes. The right level of activity and the choice of medications can differ from person to person, so individualized advice is important. Emotional support may also help, especially for those coping with pregnancy loss or a major clotting event.

When to seek medical care

Medical advice should be sought promptly if there are symptoms of a possible blood clot, such as one-sided leg swelling, sudden chest pain, shortness of breath, or coughing up blood. Emergency care is needed right away for signs of stroke, including sudden weakness, trouble speaking, confusion, severe headache, or vision loss.

People should also contact a doctor if they have repeated miscarriages, a history of stillbirth, severe pregnancy complications, or a strong personal or family history of unusual clotting. Anyone already diagnosed with APS should seek care if they become pregnant, are planning surgery, have prolonged immobility, or notice unusual bleeding while on treatment. Early evaluation can help reduce complications and clarify the safest next steps.

Frequently asked questions

Is antiphospholipid syndrome the same as lupus?

No. Antiphospholipid syndrome can occur by itself or together with lupus, but they are not the same condition. Some people with lupus develop antiphospholipid antibodies, while others with APS do not have lupus at all.

Can someone have antiphospholipid antibodies without having APS?

Yes. A person can test positive for antiphospholipid antibodies and never develop blood clots or pregnancy complications. APS is diagnosed only when the antibody pattern is present and there is a compatible clinical history.

Does APS always cause symptoms?

No. Some people do not know they have APS until they have a clot or a pregnancy complication. Others are found during testing after an unexplained event or while being evaluated for an autoimmune disease.

Can antiphospholipid syndrome be cured?

There is no simple cure that removes APS permanently. However, many people manage it successfully with monitoring, treatment to lower clot risk, and control of other health factors that can contribute to clotting.

Is pregnancy possible with antiphospholipid syndrome?

Yes, many people with APS can have successful pregnancies with specialist care. Early planning, close monitoring, and treatment tailored to pregnancy can help reduce the risk of miscarriage and other complications.

What kind of doctor treats antiphospholipid syndrome?

APS is often managed by a team that may include a hematologist, rheumatologist, internist, neurologist, or maternal-fetal medicine specialist, depending on symptoms. The right specialist mix depends on whether the main concern is clotting, pregnancy, or another autoimmune condition.

References

• National Heart, Lung, and Blood Institute
• American College of Rheumatology
• Centers for Disease Control and Prevention
• National Institute of Arthritis and Musculoskeletal and Skin Diseases
• American Society of Hematology

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.